MODERN POTENTIALS FOR THE TREATMENT OF POSTINFECTIOUS COUGH
- Autores: Edzhe M.A1, Ovchinnikov A.Y.1, Khon E.M1
-
Afiliações:
- SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH
- Edição: Nº 4 (2016)
- Páginas: 62-65
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/288730
- ID: 288730
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The article presents the results of an analysis of the literature on the issue of post-infectious cough. The urgency of the matter is due to the high prevalence of patients with this pathology, both among adults and children. There is a lack of clarity of etiopathogenesis and lack of clear treatment algorithm. Among the medication used for the treatment of post-infectious cough, mucoactive drugs have good efficacy. In particular, drug Eucabal has complex mucolytic, expectorant and anti-inflammatory action. The studies have shown efficacy of Eucabal in patients with acute and subacute cough after acute respiratory viral infections, as well as good tolerance among the different age categories of patients, including infants.
Palavras-chave
Texto integral
Sobre autores
M. Edzhe
SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH
A. Ovchinnikov
SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH
Email: lorent1@mail.ru
MD, Prof., Head of Department of Otorhinolaryngology
E. Khon
SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH
Bibliografia
- Leder K., Sinclair M., Mitakakis T. A community-based study of respiratory episodes in Melbourne Australia. Aust N Z J Public Health. 2003;27:399-404.
- Irwin R.S., Madison J.M. The diagnosis and treatment of cough. N. Engl. J. Med. 2000;343:1715-21.
- Braman S.S. Postinfectious Cough: ACCP Evidence-Based Clinical Practice Guidelines. Chest. 2006;129(1):138-46.
- Аверьянов А.В. Кашель. В кн. Пульмонология: национальное руководство / Под ред. акад. А.Г. Чучалина. М., 2009. Т. 1. C. 165-76.
- Corne J.M., Holgate S.T. Mechanisms of virus induced exacerbations of asthma. Thorax. 1997;52:380-89.
- Zimmerman B., Silverman F.S., Tarlo S.M., Chapman K.R., Kubay J.M., Urch B. Induced sputum: comparison of postinfectious coughwith allergic asthma in children. J. Allergy Clin. Immunol. 2000;105: 95-99.
- Miyashita N., Fukano H., Yoshida K., Niki Y., Matsushima T. Chlamydia pneumonia infection in adult patients with persistent cough. J. Med. Microbiol. 2003;52: 265-69.
- Chu H.W., Campbell J.A., Harbeck R.J., Martin R.J. Effects of inhaled fluticasone on bronchial hyperresponsiveness and airway inflammation in Mycoplasma pneumoniae-infected mice. Chest. 2003;123(suppl):427.
- Curley F.J., Irwin R.S., Pratter M.R., Stivers D.H., Doern G.V., Vernaglia P.A., Larkin A.B., Baker S.P. Cough and the common cold. Am Rev Respir Dis. 1988;138:305-11.
- Holmes P.W., Barter C.E., Pierce R.J. Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection. Respir Med. 1992; 86:425-29.
- Ващенко Л.В., Вакуленко Л.И. Оптимизация патогенетического лечения острой респираторной инфекции у детей. Совр. педиатрия. 2009;2(24):64-71.
- Тарасова Г.Д. Тактика мукоактивной терапии при воспалительных заболеваниях в оториноларингологии. Педиатрия. 2005;7(2):8-9.
- Зайцева О.В. Лечение кашля у детей и подростков: рациональный выбор терапии. Consilium medicum. 2003;5(4):204-7.
- Chalumeau M., Cheron G., Assathiany R., Moulin F., Bavoux F., Breart G., Pons G. Mucolitic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem? Arch. Pediatr. 2002;9:1128-36.
- Шадрин О.Г., Гайдучик Г.А. Эффективность и безопасность ингаляционного метода лечения острых бронхитов у детей с использованием Эвкабала бальзама. Здоровье ребенка. 2012;7(42):28-32.
- Татаренко О. Эвкабал - эффективное, безопасное и доступное лечение. Medical Nature. 2013;1(13):25.
- Ciuman R.R. Phytotherapeutic and naturopathic adjuvant therapies in otorhinolaryngology. Eur. Arch. Otorhinolaryngol. 2012;269(2):389-97.
- Sienkiewicz M., Glowacka A., Poznanska-Kurowska K., Kaszuba A., Urbaniak A., Kowalczyk E. The effect of clary sage oil on staphylococci responsible for wound infec tions. Postepy Dermatol Alergol. 2015; 32(1):21-6.
- Dorman H.J., Deans S.G. Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J. Appl. Microbiol. 2000;88(2):308-16.
Arquivos suplementares
